Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-811-2 | CAS number: 126-91-0
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- other: LuSens Assay
Test material
- Reference substance name:
- (R)-3,7-dimethyl-1,6-octadien-3-ol
- EC Number:
- 204-811-2
- EC Name:
- (R)-3,7-dimethyl-1,6-octadien-3-ol
- Cas Number:
- 126-91-0
- Molecular formula:
- C10H18O
- IUPAC Name:
- (3R)-3,7-dimethylocta-1,6-dien-3-ol
- Test material form:
- liquid
Constituent 1
Results and discussion
- Positive control results:
- EGDMA (120 µM) was used as positive control. The viability was above 70 % and a dis-tinct increase in luciferase induction above 2.5 fold in comparison to the solvent control was detected. This luciferase induction is well within the historical data range of the posi-tive control.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: experiment I
- Parameter:
- other: Induction of Luciferase(fold)
- Value:
- 1.5
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: In the Luciferase assay, a dose-dependent effect was detected. At the concentrations 804 µM to 2000 µM the luciferase induction was above the threshold of 1.5 fold in com-parison to the solvent control.
- Key result
- Run / experiment:
- other: experiment I
- Parameter:
- other: Relative Viability (%)
- Value:
- 83
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: Experiment II
- Parameter:
- other: Induction of Luciferase(fold)
- Value:
- 1.5
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: In the Luciferase assay, a dose-dependent effect was detected. At the concentrations 558 µM to 2000 µM the luciferase induction was above the threshold of 1.5 fold in com-parison to the solvent control.
- Key result
- Run / experiment:
- other: experiment II
- Parameter:
- other: Relative Viability (%)
- Value:
- 76.9
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- Each valid experiment (i.e. meeting all acceptance criteria, according to the procedure described above) is interpreted as follows:
A test compound is considered to have the potential to activate the Nrf2 transcription factor if the luciferase induction is above or equal to 1.5 fold compared to the vehicle control in 2 (or more than) consecutive non-cytotoxic (relative viability ≥ 70 %) tested concentrations whereby at least three tested concentrations must be non-cytotoxic in two independent valid experiments.
A test compound is considered not to have the potential to activate the Nrf2 transcription factor if the effects mentioned above are not observed.
In order to come to a conclusion on the skin sensitization hazard of a substance, a mini-mum of two valid and independent experiments needs to indicate a positive or negative result according to the above-described criteria. If the first two experiments come to the same result (i.e. either being negative or being positive) no further testing is required. In case that the first two experiments give discordant results (i.e. one is negative and the other is positive), a third independent experiment needs to be conducted to complete the study. The skin sensitizing potential (corresponding to the potential to activate the Nrf2 transcription factor) of a test substance is determined by the result of the majority of the repetitions of an experiment. If two of two or two of three experiments are negative/positive, the substance is considered as negative/positive.
The luciferase induction was above 1.5 fold in more than 2 consecutive non-cytotoxic test item concentrations in experiment I and II.
Therefore, the test item (R)-3,7-dimethyl-1,6-octadien-3-ol is considered to have the poten-tial to activate the Nrf2 transcription factor (sensitizing potential) under the conditions of the LuSens test
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
